Blood pressure control rates with an antihypertensive regimen including trandolapril in a canadian usual-care setting

Abstract

Trandolapril demonstrated a favorable safety and effectiveness profile. SBP reductions of approximately 20 mm Hg and control rates > 65% could be achieved over 6 months.